Vyne Therapeutics Inc. (VYNE)
NASDAQ · Healthcare
Vyne Therapeutics Inc. Shareholder Equity 2016–2025
Vyne Therapeutics Inc. annual/quarterly shareholder equity history from 2016 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Vyne Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 27.8M, a 46.69% decrease year-over-year.
- Vyne Therapeutics Inc. shareholder equity for 2025 were 27.8M, a 46.69% decrease from 2024.
- Vyne Therapeutics Inc. shareholder equity for 2024 were 52.1M, a 41.30% decrease from 2023.
- Vyne Therapeutics Inc. shareholder equity for 2023 were 88.7M, a 184.39% increase from 2022.
- Vyne Therapeutics Inc. shareholder equity for 2022 were 31.2M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Vyne Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $28 |
| 2024 | $52 |
| 2023 | $89 |
| 2022 | $31 |
| 2021 | $49 |
| 2020 | $37 |
| 2019 | $18 |
| 2018 | $92 |
| 2017 | $69 |
| 2016 | $-29 |
| Vyne Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $28 |
| 2024-12-31 | $52 |
| 2023-12-31 | $89 |
| 2022-12-31 | $31 |
| 2021-12-31 | $49 |
| 2020-12-31 | $37 |
| 2019-12-31 | $18 |
| 2018-12-31 | $92 |
| 2017-12-31 | $69 |
| 2016-12-31 | $-29 |
Vyne Therapeutics Inc. Shareholder Equity — FAQ
Vyne Therapeutics Inc. (VYNE) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VYNE's shareholder equity history?
The chart and table above show Vyne Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.